Cargando…
The new insight of treatment in Cholangiocarcinoma
Cholangiocarcinoma (CCA) is a relatively rare malignant tumor originating from the bile duct epithelial cells, and it is one of the malignant tumors with fast growth in incidence and death rate in recent years. CCA carries a very poor prognosis due to a typically late clinical presentation and a poo...
Autores principales: | Li, Yuhang, Song, Yinghui, Liu, Sulai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771522/ https://www.ncbi.nlm.nih.gov/pubmed/35069894 http://dx.doi.org/10.7150/jca.68264 |
Ejemplares similares
-
The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022) -
Correction to: The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022) -
Insights into the role of STAT3 in intrahepatic cholangiocarcinoma
por: Yang, Ranzhiqiang, et al.
Publicado: (2022) -
Mechanisms underlying the changes in acetaldehyde dehydrogenase 1 in cholangiocarcinoma
por: Ding, Bai, et al.
Publicado: (2023) -
Progress in gallbladder cancer with lymph node metastasis
por: Li, Yuhang, et al.
Publicado: (2022)